Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
第一作者:
Li,Chen
第一单位:
Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.;Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
作者:
医学主题词
乳腺肿瘤(Breast Neoplasms);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy);列线图(Nomograms);预后(Prognosis)
DOI
10.3389/fimmu.2022.831848
PMID
35320931
发布时间
2022-05-02
- 浏览1
Frontiers in immunology
831848页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



